Frontiers in Immunology | Vaccines and Molecular Therapeutics

Correction

Published on 19 Sep 2025

Correction: Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis

in Vaccines and Molecular Therapeutics

Clara Sánchez-Menéndez
Alejandro Zurdo
Magdalena Corona
Elena Mateos de la Morenas
Sara Rodríguez-Mora
Guiomar Casado
Javier García-Pérez
Mayte Pérez-Olmeda
Susana Domínguez
María Aránzazu Murciano-Antón

Frontiers in Immunology

doi 10.3389/fimmu.2025.1706723

1,442 views

Original Research

Published on 18 Sep 2025

Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in mice

in Vaccines and Molecular Therapeutics

Alena Reguzova
Verena Haug
Carina Metz
Melanie Müller
Madeleine Fandrich
Alex Dulovic
Ralf Amann

Frontiers in Immunology

doi 10.3389/fimmu.2025.1675859

2,385 views
2 citations

Review

Published on 18 Sep 2025

Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons

in Vaccines and Molecular Therapeutics

Rodney Ogwang
Mohamed Adan
Philip Bejon
Melissa C. Kapulu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1672945

3,821 views
1 citation

Review

Published on 16 Sep 2025

Review of advanced research on swine Actinobacillus pleuropneumoniae vaccine development strategy

in Vaccines and Molecular Therapeutics

Adehanom Baraki Tesfaye
Rui Han
Zhengyu Tao
Liuchao You
Jiayao Zhu
Pengcheng Gao
Lei Fu
Yuefeng Chu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1645610

3,719 views
1 citation

Clinical Trial

Published on 16 Sep 2025

No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCT

in Vaccines and Molecular Therapeutics

Sinead Delany-Moretlwe
Hakim-Moulay Dehbi
Izukanji Sikazwe
George Kyei
Kwadwo Koram
Erik Dubberke
Noluthando Mwelase
Dominic Hague
Linda-Gail Bekker
Linda Yun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1588190

3,109 views

Original Research

Published on 15 Sep 2025

Comparative single-cell immune responses in peripheral blood and lymph node of immunized SARS-CoV-2 challenged infant rhesus macaques

in Vaccines and Molecular Therapeutics

Sasha Anronikov
Cameron Meikle
Emma C. Milligan
Han Chen
Nilanjan Mukherjee
Zach Bjornson
Brice Gaudillière
Sizun Jiang
Sallie R. Permar
Koen K. A. Van Rompay

Frontiers in Immunology

doi 10.3389/fimmu.2025.1599408

3,618 views

Original Research

Published on 15 Sep 2025

Modified recombinant collagen-peptide/gallic acid grafted chitosan composites with antibacterial and antioxidant property for wound dressing: a preliminary study

in Vaccines and Molecular Therapeutics

Yu Chen
Wenjie Wen
Jie Wang
Shiting Huang
Qianqian Ren
Jiayao Cai
Songlin Zhou
Rui Li
Dandan Ren
Liaotian Peng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1675212

2,029 views

Original Research

Published on 12 Sep 2025

Virus-like particles containing the extracellular domain of G protein in combination with a CTL peptide of M2 elicit protection against respiratory syncytial virus infection without pulmonary disease

in Vaccines and Molecular Therapeutics

Huan Qin
Jin Luo
Zishu Pan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1625670

2,622 views

Original Research

Published on 12 Sep 2025

Immunization route-mediated differences in long-term maturation of humoral immune response induced by adenovirus vector-based COVID-19 vaccine Sputnik V in nonhuman primates

in Vaccines and Molecular Therapeutics

Amir I. Tukhvatulin
Ilya V. Gordeychuk
Alina S. Dzharullaeva
Inna V. Dolzhikova
Ekaterina O. Bayurova
Fatima M. Izhaeva
Anna V. Kovyrshina
Alla S. Zhitkevich
Daria V. Avdoshina
Stanislav A. Gulyaev

Frontiers in Immunology

doi 10.3389/fimmu.2025.1634187

3,048 views

Correction

Published on 12 Sep 2025

Correction: Protection against N. gonorrhoeae induced by OMV-based meningococcal vaccines are associated with cross-species directed humoral and cellular immune responses

in Vaccines and Molecular Therapeutics

Weiyan Zhu
Andreea Waltmann
Marguerite B. Little
Kristie L. Connolly
Kathryn A. Matthias
Keena S. Thomas
Mary C. Gray
Aleksandra E. Sikora
Alison K. Criss
Margaret C. Bash

Frontiers in Immunology

doi 10.3389/fimmu.2025.1697855

1,618 views

Original Research

Published on 11 Sep 2025

Elevating MHC I expression on tumor cells by nanovesicles loading tyrosine kinase inhibitors can improve the efficacy of cancer vaccines

in Vaccines and Molecular Therapeutics

Huimin Xie
Lin Ma
Xiaoli He
Songsong Zhao
Jin Wang
Ao Zhu
Changming Liu
Olga Piskareva
Chao Deng
Fenghua Meng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1653533

2,786 views

Editorial

Published on 11 Sep 2025

Editorial: Community series in development and harmonization of assays and models to assess immunogenicity and correlates of protection of vaccines against pathogens causing respiratory infections, volume 2

in Vaccines and Molecular Therapeutics

Geert Leroux-Roels
Donata Medaglini

Frontiers in Immunology

doi 10.3389/fimmu.2025.1670957

1,968 views

Original Research

Published on 10 Sep 2025

Mature dengue virus particles inactivated by a non-ionic detergent retain quaternary neutralizing epitopes and induce potent neutralizing antibodies

in Vaccines and Molecular Therapeutics

Wen-Yang Tsai
Theodore C. Pierson
Jens Wrammert
Wanwisa Dejnirattisai
Amonrat Jumnainsong
Juthathip Mongkolsapaya
Gavin Screaton
James E. Crowe
Wei-Kung Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1626823

2,321 views

Review

Published on 05 Sep 2025

Antigen-presenting cell internalization is key for understanding and evaluating therapeutic antibodies’ immunogenicity

in Vaccines and Molecular Therapeutics

Maria Lteif
Marc Pallardy
Isabelle Turbica

Frontiers in Immunology

doi 10.3389/fimmu.2025.1617395

3,411 views
1 citation

Original Research

Published on 05 Sep 2025

Reduced spike specific T-cell responses in COVID-19 vaccinated subjects undergoing SARS-CoV-2 breakthrough infection

in Vaccines and Molecular Therapeutics

Stefania Varchetta
Federica Sole Golfetto
Patrizia Bono
Annapaola Callegaro
Tanya Fabbris
Andrea Favalli
Mariacristina Crosti
Tullia Maria De Feo
Nathalie Iannotti
Giorgio Bozzi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1657082

3,752 views
1 citation

Clinical Trial

Published on 05 Sep 2025

Preliminarily evaluation the safety and immunogenicity of tetanus, reduced diphtheria and acellular pertussis (five components) combined vaccine, adsorbed (Tdcp) in participants aged 6 years and above: a blinded and randomised, and controlled phase I clinical trial

in Vaccines and Molecular Therapeutics

Xiaoyu Liu
Chen Wei
Haitao Huang
Jingxuan Wan
Yajun Li
Feiyu Wang
Siwen Li
Ying Wang
Xuewen Wang
Xue Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1616574

3,099 views

Original Research

Published on 04 Sep 2025

Antibodies elicited by altSonflex1-2-3 GMMA vaccine are bactericidal against a panel of drug-resistant Shigella clinical isolates

in Vaccines and Molecular Therapeutics

Elena Boero
Roberta Di Benedetto
Giacomo Vezzani
Renzo Alfini
Pieter-Jan Ceyssens
Giannoula S. Tansarli
Ferric C. Fang
Carla Fontana
Alberto Rossi
Stefania Carrara

Frontiers in Immunology

doi 10.3389/fimmu.2025.1652460

2,133 views

Original Research

Published on 03 Sep 2025

The impact of mycobacteria-induced trained immunity on SARS-CoV-2 vaccine responses

in Vaccines and Molecular Therapeutics

Lidia Sánchez-Morales
Néstor Porras
Andrea Pérez-Domingo
Marta Pérez-Sancho
Teresa García-Seco
Marta Diaz-Frutos
Aranzazu Buendia
Inmaculada Moreno
Leydis Zamora
Ana Balseiro

Frontiers in Immunology

doi 10.3389/fimmu.2025.1633977

2,825 views
3 citations

Clinical Trial

Published on 03 Sep 2025

Immunogenicity and safety of co-administration with the Sabin-strain-based inactivated poliovirus vaccine (vero cell) and the diphtheria-tetanus-acellular pertussis vaccine in eligible children in China: a randomized, controlled, multicenter, non-inferiority trial

in Vaccines and Molecular Therapeutics

Xiaoyu Liu
Shasha Han
Xiao Chen
Li Sun
Ruize Wang
Xuanwen Shi
Yu Guo
Hui Wang
Haiping Chen
Shaoying Chang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1633170

2,409 views
2 citations

Review

Published on 03 Sep 2025

MS2 virus-like particles as a versatile platform for multi-disease vaccines: a review

in Vaccines and Molecular Therapeutics

Guodong Zhou
Zhili Luo
Zhihui Zhang
Shengliang Cao
Yubao Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1651594

4,071 views
3 citations

Original Research

Published on 02 Sep 2025

Harnessing outer membrane vesicles derived from Bordetella pertussis to overcome key limitations of acellular pertussis vaccines

in Vaccines and Molecular Therapeutics

Lucía Locati
Daniela Bottero
Francisco Carriquiriborde
Oriana López
Bernarda Pschunder
Eugenia Zurita
Pablo Martin Aispuro
Maria Emilia Gaillard
Daniela Hozbor

Frontiers in Immunology

doi 10.3389/fimmu.2025.1655910

2,702 views
1 citation

Original Research

Published on 02 Sep 2025

Upper respiratory tract immunization with Pam2Cys-adjuvanted spike protein vaccine achieves sterilizing protection against SARS-CoV-2

in Vaccines and Molecular Therapeutics

Erica L. Stewart
Skye Stockdale
Matt D. Johansen
Lachlan Smith
Sibel Alca
Joshua W. C. Maxwell
Duc H. Nguyen
Stefan Miemczyk
Guanshu Zhao
Stuart Turville

Frontiers in Immunology

doi 10.3389/fimmu.2025.1654126

6,355 views

Original Research

Published on 01 Sep 2025

Evaluation of a multi-epitope vaccine PME for Pasteurella multocida in mouse model

in Vaccines and Molecular Therapeutics

Rui Zhang
Lu Dai
Yizhen Jia
Haoran Qi
Junfeng He
Jiaxin Cheng
Xuejun Gao
Liancheng Lei
Feng Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1652907

3,185 views
1 citation

Mini Review

Published on 01 Sep 2025

Immunomodulatory biomaterials in HIV-1 infection prevention, control and treatment

in Vaccines and Molecular Therapeutics

Jiaying Li
Huan Tang
Xiaoyi Zhou
Zijun Ni
Yuxin Liang
Xinyue Sun
Xun Zhuang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1670423

2,487 views
1 citation